Cargando…
Striking balance between expedited review and expecting efficacious anticancer drug and biologics: An ongoing challenge
OBJECTIVE: The objective of this study is to assess the postmarketing status: Efficacy and safety drugs and biologics related with cancer approved under expedited review. METHODS: This observational, analytical study was carried between January and April 2016 by the Department of Pharmacology and Me...
Autores principales: | Chary, Krishnan Vengadaragava, Ramesh, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654217/ https://www.ncbi.nlm.nih.gov/pubmed/29109935 http://dx.doi.org/10.4103/2229-3485.215971 |
Ejemplares similares
-
Expedited drug review process: Fast, but flawed
por: Chary, Krishnan Vengadaraga
Publicado: (2016) -
Another feather in the crown of medical safety and ethics in India
por: Chary, Krishnan Vengadaragava
Publicado: (2017) -
A rare case modafinil dependence
por: Krishnan, Raman, et al.
Publicado: (2015) -
Expectations and Disappointments: The War and the Strikes
Publicado: (1919) -
Comparability Considerations and Challenges for Expedited Development Programs for Biological Products
por: Schrieber, Sarah J., et al.
Publicado: (2020)